[Hiring] Senior Director Marketing @Revolution Medicines

Role Description

Reporting directly to the Executive Director of Marketing, the marketing leader will help develop and deliver Revolution Medicine’s marketing plans for one of the company’s lead KRAS programs in preparation for anticipated launches.

• Work within the Commercial team to define the marketing strategy and tactically deliver critical marketing activities on the Commercial roadmap, such as:
  • Market research and patient journey mapping
  • Branding, messaging, and content delivery
• Collaborate with cross-functional teams to provide a commercial marketing perspective on clinical, medical affairs, and market access initiatives.
• Grow your team to support expanding marketing needs.
• This position is based out of our headquarters in Redwood City, CA.

• Partner to shape the strategic marketing plan and oversee launch readiness initiatives based on deep customer insight.
• Develop branding, positioning, messages, story flow, and creative imagery to prepare for and deliver successful oncology product launches.
• Lead the development and implementation of the therapeutic focused promotional platform (e.g., messaging, market research initiatives, unbranded website, etc.).
• Prioritize, develop, and implement promotional and disease education tactics (including print and digital promotions, peer-to-peer programming, and key customer marketing initiatives) that establish value with customers and contribute to achieving a successful product launch.
• Lead partner agency and vendor relationships and workflow.
• Operate as an ambassador of the company, establishing the organization as a trusted member of the healthcare community to all relevant stakeholders (Patients, HCPs, Payers, Policy makers, Industry peers).
• Develop the Customer Marketing Team to understand the needs of top institutions, key opinion leaders, the competitor landscape, and other important healthcare providers to optimize promotional approach, selling tools, and educational programming.
• Demonstrate the ability to quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics.
• Establish a strong relationship with medical affairs, and eventually, the sales team and other field-based commercial teams to ensure optimal execution; partner with Sales Training to develop a comprehensive and effective training plan.
• Participate in cross-functional teams as marketing lead to gather input for functional activities and ensure alignment with marketing messaging (e.g., with clinical development, medical affairs, and investor relations).
• Ensure strategic and tactical plans meet compliance and regulatory guidelines and company policies.
• Deliver marketing operating expenses within budget.
• Travel as needed.
• Other duties as assigned.

Qualifications

• Bachelor’s degree required (MBA preferred) with at least 12+ years of progressive commercial experience in a biotechnology and/or pharmaceutical company.
• Successful history of developing and executing marketing strategies.
• Experience in leading the launch of new products.
• Demonstrated ability to derive insights/analytics leading to the development of innovative marketing strategies.
• Strong leadership, with the ability to work well cross-functionally and influence across an organization at all levels.
• Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
• Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication.
• Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.

Requirements

• Proven experience in a smaller, rapidly growing company.
• Targeted oncology product experience strongly preferred.
• Sales experience and ideally sales or field leadership.

Benefits

• Base pay salary range for this full-time position is $244,000 - $305,000 USD.
• Competitive cash compensation.
• Robust equity awards.
• Strong benefits.
• Significant learning and development opportunities.

Company Description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

• The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
• Current clinical developments include:
  • daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor
  • elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor
  • zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor
  • RMC-5127, a RAS(ON) G12V-selective inhibitor